ELV
Elevance Health Inc.
NYSE · USHealthcareMedical - Healthcare Plans
$382.23+2.44%
Price as of Jul 20, 2026
ELV valuation
Elevance Health Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 13.56x
- P/E 2026E
- 14.79x
- P/E 2027E
- 13.06x
- P/E 2028E
- 10.93x
- P/S forward
- 0.42x
Trailing multiples
- P/E TTM
- 16.99x
- PEG TTM
- 0.68x
- Price / book
- 1.85x
- Price / sales
- 0.41x
- Price / cash flow
- 11.12x
Enterprise value
- Enterprise value
- $76.7B
- EV / sales
- 0.38x
- EV / EBITDA
- 9.58x
- EV / EBIT
- 10.86x
- Market cap
- $83.0B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.